{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:40:45Z","timestamp":1789771245309,"version":"4.0.1"},"reference-count":157,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular imaging is integral to modern clinical trials of new pharmaceuticals or devices, enabling refined eligibility, mechanistic insight, and sensitive assessment of treatment response and safety. Potential heterogeneity in data acquisition, analysis, and reporting may affect reproducibility and interpretability across multicentre settings. Rigorous standardization and fit-for-purpose validation of imaging endpoints can improve statistical efficiency, reduce trial duration and cost, and strengthen generated evidence. This Scientific Statement outlines a reference framework for the implementation of cardiovascular imaging in clinical trials. We provide considerations on use of imaging parameters as eligibility criteria in clinical trials, for efficacy signals evaluation, and for assessment of safety. We define principles for clinical, analytical, and operational validation of imaging endpoints, and discuss concepts of minimal clinically important change and minimal detectable change. Additionally, we discuss feasibility considerations for use of cardiovascular imaging endpoints in multicentre clinical trials where differences in equipment and local experience may exist. We delineate standards for harmonization, centralized analysis, and quality control in clinical trials, as well as challenges and opportunities of the integration of artificial intelligence within core-lab workflows. Lastly, we identify gaps in knowledge, challenge of preclinical\u2013clinical translatability and highlight training needs and innovation priorities.<\/jats:p>","DOI":"10.1093\/ehjci\/jeag171","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:41:49Z","timestamp":1782916909000},"page":"1585-1602","source":"Crossref","is-referenced-by-count":1,"title":["Reference framework for implementation of cardiovascular imaging in clinical trials: a scientific statement of the European Association of Cardiovascular Imaging of the ESC"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5334-8551","authenticated-orcid":false,"given":"Elena","family":"Surkova","sequence":"first","affiliation":[{"name":"Translational Sciences and Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca , 1 Francis Crick Avenue, Cambridge CB2 0AA ,","place":["UK"]},{"name":"Royal Brompton and Harefield Hospitals, Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust , Sydney Street, London SW3 6NP ,","place":["UK"]},{"name":"National Heart and Lung Institute, Imperial College London , Guy Scadding Building, Cale Street, London SW3 6LY ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Gimelli","sequence":"additional","affiliation":[{"name":"Imaging Department, Fondazione Toscana Gabriele Monasterio , Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0938-3170","authenticated-orcid":false,"given":"Andreas A","family":"Giannopoulos","sequence":"additional","affiliation":[{"name":"Department of Nuclear Cardiology, Cardiac Imaging, University Hospital Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7208-5769","authenticated-orcid":false,"given":"Nina Ajmone","family":"Marsan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Center , Albinusdreef 2, Leiden 2300 RC ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8261-4529","authenticated-orcid":false,"given":"Andrea","family":"Baggiano","sequence":"additional","affiliation":[{"name":"Perioperative Cardiology and Cardiovascular Imaging Department, Centro Cardiologico Monzino IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4772-5549","authenticated-orcid":false,"given":"Maja","family":"Cikes","sequence":"additional","affiliation":[{"name":"University of Zagreb School of Medicine, Department of Cardiovascular Diseases, University Hospital Center Zagreb , Zagreb ,","place":["Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-6705","authenticated-orcid":false,"given":"Anna","family":"Baritussio","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padua University Hospital , Padua ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-6935","authenticated-orcid":false,"given":"Arti A","family":"Ramkisoensing","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Center , Albinusdreef 2, Leiden 2300 RC ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9847-5917","authenticated-orcid":false,"given":"Marc R","family":"Dweck","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh , Chancellors Building, Little France Crescent, Little France, Edinburgh EH16 4SB ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0587-050X","authenticated-orcid":false,"given":"Maribel","family":"Gonzalez-del-Hoyo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, University Hospital Zurich, University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7416-871X","authenticated-orcid":false,"given":"Jaume","family":"Aguero","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital Univeristario y Politecnico La Fe , Valencia ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6324-6874","authenticated-orcid":false,"given":"Philippe B","family":"Bertrand","sequence":"additional","affiliation":[{"name":"Deparment of Cardiology, Ziekenhuis Oost-Limburg , Genk ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9233-9831","authenticated-orcid":false,"given":"Marianna","family":"Fontana","sequence":"additional","affiliation":[{"name":"National Amyloidosis Centre, University College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4846-8529","authenticated-orcid":false,"given":"Riccardo M","family":"Inciardi","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4696-9610","authenticated-orcid":false,"given":"Michael T","family":"Lu","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School , Boston MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9841-2737","authenticated-orcid":false,"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[{"name":"Institut del Cor, Hospital Universitari Germans Trias i Pujol, Badalona ,","place":["Spain"]},{"name":"Centre of Comparative Medicine and Bioimaging, Institute of Research Germans Trias i Pujol, Badalona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"2026090105472083900_jeag171-B1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jcmg.2025.03.017","article-title":"Accelerating drug translation: role of coronary computed tomography angiography plaque imaging candidates as surrogate biomarkers","volume":"18","author":"Baskaran","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.echo.2009.05.020","article-title":"Echocardiographic imaging in clinical trials: American Society of Echocardiography Standards for echocardiography core laboratories: endorsed by the American College of Cardiology Foundation","volume":"22","author":"Douglas","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"2026090105472083900_jeag171-B3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jchf.2019.12.011","article-title":"Endpoints in heart failure drug development: history and future","volume":"8","author":"Fiuzat","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2026090105472083900_jeag171-B4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation"},{"key":"2026090105472083900_jeag171-B5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jama.2017.9414","article-title":"Characteristics of clinical studies used for US food and drug administration approval of high-risk medical device supplements","volume":"318","author":"Zheng","year":"2017","journal-title":"JAMA"},{"key":"2026090105472083900_jeag171-B6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jacc.2025.06.036","article-title":"Evidentiary landscape of heart failure therapies, regulatory decisions, and translation into guidelines","volume":"86","author":"Kaul","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026090105472083900_jeag171-B7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1687-9856-2011-7","article-title":"Efficacy of leuprolide acetate 1-month depot for central precocious puberty (CPP): growth outcomes during a prospective, longitudinal study","volume":"2011","author":"Lee","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"2026090105472083900_jeag171-B8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"2026090105472083900_jeag171-B9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N Engl J Med"},{"key":"2026090105472083900_jeag171-B10","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N Engl J Med"},{"key":"2026090105472083900_jeag171-B11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"2026090105472083900_jeag171-B12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41569-025-01180-9","article-title":"Challenges and opportunities in assessing right ventricular structure and function: a roadmap for standardization, clinical implementation and research","volume":"23","author":"Kovacs","year":"2026","journal-title":"Nat Rev Cardiol"},{"key":"2026090105472083900_jeag171-B13","author":"Administration USFaD"},{"key":"2026090105472083900_jeag171-B14","volume-title":"Clinical Trial Imaging Endpoint Process Standards","author":"Administration USFaD","year":"2018"},{"key":"2026090105472083900_jeag171-B15","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.jcin.2016.11.053","article-title":"SAPIEN s3 leaflet malfunction with severe intravalvular aortic insufficiency immediately post-deployment","volume":"10","author":"Singh","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2026090105472083900_jeag171-B16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ehjci\/jead196","article-title":"Phenotyping heart failure by echocardiography: imaging of ventricular function and haemodynamics at rest and exercise","volume":"24","author":"Smiseth","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s44156-025-00083-2","article-title":"Clinical research and trials in echocardiography: rationale, requirements and future opportunities","volume":"12","author":"Johnson","year":"2025","journal-title":"Echo Res Pract"},{"key":"2026090105472083900_jeag171-B18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrcardio.2017.1","article-title":"Advanced imaging in valvular heart disease","volume":"14","author":"Bax","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2026090105472083900_jeag171-B19","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2026090105472083900_jeag171-B20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/eurjhf\/hft052","article-title":"Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)","volume":"15","author":"McMurray","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026090105472083900_jeag171-B21","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.1536","article-title":"Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-reduced trial","volume":"21","author":"Packer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026090105472083900_jeag171-B22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jchf.2017.04.013","article-title":"Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: rationale and design of the PARAGON-HF trial","volume":"5","author":"Solomon","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026090105472083900_jeag171-B23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/ejhf.2249","article-title":"Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial","volume":"23","author":"Solomon","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026090105472083900_jeag171-B24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/ejhf.1596","article-title":"Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-preserved trial","volume":"21","author":"Anker","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026090105472083900_jeag171-B25","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/ejhf.3253","article-title":"Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: rationale and design of the FINEARTS-HF trial","volume":"26","author":"Vaduganathan","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026090105472083900_jeag171-B26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/ehjci\/jeaf026","article-title":"The role of multi-modality imaging in multiple valvular heart diseases: a clinical consensus statement of the European Association of Cardiovascular Imaging of the European Society of Cardiology","volume":"26","author":"Donal","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jcmg.2025.03.003","article-title":"The last decade in tricuspid regurgitation: how imaging shaped a field","volume":"18","author":"Hahn","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B28","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"2026090105472083900_jeag171-B29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ehjci\/jeaf351","article-title":"Randomized controlled trials in valvular heart disease: the evolving role of multimodality imaging","volume":"27","author":"Tastet","year":"2026","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B30","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1093\/eurheartj\/ehad510","article-title":"Cardiac magnetic resonance biomarkers as surrogate endpoints in cardiovascular trials for myocardial diseases","volume":"44","author":"Benz","year":"2023","journal-title":"Eur Heart J"},{"key":"2026090105472083900_jeag171-B31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12916-025-04226-4","article-title":"Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers","volume":"23","author":"Croon","year":"2025","journal-title":"BMC Med"},{"key":"2026090105472083900_jeag171-B32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jcmg.2016.09.031","article-title":"Trials testing the value of imaging use in valve disease and in transcatheter valvular interventions","volume":"10","author":"Leipsic","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ehjci\/jeaf014","article-title":"The role of multi-modality imaging for the assessment of left atrium and left atrial appendage: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)","volume":"26","author":"Sade","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B34","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcmg.2020.11.012","article-title":"CT angiography followed by invasive angiography in patients with moderate or severe ischemia-insights from the ISCHEMIA trial","volume":"14","author":"Mancini","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B35","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2967\/jnumed.119.240440","article-title":"The changing face of nuclear cardiology: guiding cardiovascular care toward molecular medicine","volume":"61","author":"Werner","year":"2020","journal-title":"J Nucl Med"},{"key":"2026090105472083900_jeag171-B36","article-title":"The role of cardiac PET in diagnosis and prognosis of patients with ischemia with no obstructive coronary arteries (INOCA)","volume":"43","author":"Al-Mallah","year":"2024","journal-title":"Am Heart J Plus"},{"key":"2026090105472083900_jeag171-B37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jcmg.2024.11.003","article-title":"Development of imaging endpoints for clinical trials in AL and ATTR amyloidosis: proceedings of the amyloidosis forum","volume":"18","author":"Dorbala","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.010600","article-title":"Diagnosis of infective endocarditis by subtype using (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography: a contemporary meta-analysis","volume":"13","author":"Wang","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jcmg.2016.12.003","article-title":"Use of imaging endpoints in clinical trials","volume":"10","author":"Gillam","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jacc.2019.05.024","article-title":"Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel","volume":"74","author":"Ibanez","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026090105472083900_jeag171-B41","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2010.05.011","article-title":"Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach","volume":"56","author":"Kramer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026090105472083900_jeag171-B42","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/ejhf.3760","article-title":"Changes in cardiac structure and function are associated with health-related quality of life in heart failure patients with reduced ejection fraction: results from the EVALUATE-HF trial","volume":"27","author":"Lee","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026090105472083900_jeag171-B43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02225-2022","article-title":"Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension","volume":"62","author":"Alabed","year":"2023","journal-title":"Eur Respir J"},{"key":"2026090105472083900_jeag171-B44","article-title":"Understanding statistical analysis in randomized trials: tips and tricks for effective review","volume":"3","author":"Frumento","year":"2025","journal-title":"Eur Heart J Imaging Methods Pract"},{"key":"2026090105472083900_jeag171-B45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s13244-013-0220-5","article-title":"ESR statement on the stepwise development of imaging biomarkers","volume":"4","author":"European Society of R","year":"2013","journal-title":"Insights Imaging"},{"key":"2026090105472083900_jeag171-B46","doi-asserted-by":"crossref","first-page":"O9","DOI":"10.1186\/1470-7330-15-S1-O9","article-title":"Translating imaging biomarkers into clinical practice","volume":"15","author":"O'Connor","year":"2015","journal-title":"Cancer Imaging"},{"key":"2026090105472083900_jeag171-B47","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jcmg.2017.11.017","article-title":"Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction","volume":"11","author":"Potter","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B48","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jcmg.2024.03.012","article-title":"Cardiac magnetic resonance evaluation of lv remodeling post-myocardial infarction: prognosis, monitoring and trial endpoints","volume":"17","author":"Gissler","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B49","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jacc.2024.04.064","article-title":"Liraglutide improves myocardial perfusion and energetics and exercise tolerance in patients with type 2 diabetes","volume":"84","author":"Chowdhary","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"3Part A","key":"2026090105472083900_jeag171-B50","article-title":"Coronary microvascular dysfunction","volume":"3","author":"Sandoval","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"2026090105472083900_jeag171-B51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular angina, and treatment strategies","volume":"8","author":"Marinescu","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026090105472083900_jeag171-B53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/ERP-18-0003","article-title":"What is the minimum change in left ventricular ejection fraction, which can be measured with contrast echocardiography?","volume":"5","author":"Suwatanaviroj","year":"2018","journal-title":"Echo Res Pract"},{"key":"2026090105472083900_jeag171-B54","doi-asserted-by":"crossref","first-page":"e1176","DOI":"10.1161\/CIR.0000000000001233","article-title":"Patient-centered adult cardiovascular care: a scientific statement from the American Heart Association","volume":"149","author":"Goldfarb","year":"2024","journal-title":"Circulation"},{"key":"2026090105472083900_jeag171-B55","first-page":"190","article-title":"Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)","volume":"46","author":"Wilkinson","year":"2025","journal-title":"Eur Heart J"},{"key":"2026090105472083900_jeag171-B56","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ejhf.2018","article-title":"Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium","volume":"22","author":"Abraham","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026090105472083900_jeag171-B57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12874-021-01228-7","article-title":"Using a distribution-based approach and systematic review methods to derive minimum clinically important differences","volume":"21","author":"Watt","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"2026090105472083900_jeag171-B58","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/sim.7679","article-title":"Performance of intraclass correlation coefficient (ICC) as a reliability index under various distributions in scale reliability studies","volume":"37","author":"Mehta","year":"2018","journal-title":"Stat Med"},{"key":"2026090105472083900_jeag171-B59","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s11136-022-03239-3","article-title":"Inferring meaningful change in quality of life with posterior predictive distribution: an alternative to standard error of measurement","volume":"32","author":"Li","year":"2023","journal-title":"Qual Life Res"},{"key":"2026090105472083900_jeag171-B60","doi-asserted-by":"crossref","first-page":"111242","DOI":"10.1016\/j.jclinepi.2023.111242","article-title":"Surrogate endpoints: a key concept in clinical epidemiology","volume":"167","author":"Christensen","year":"2024","journal-title":"J Clin Epidemiol"},{"key":"2026090105472083900_jeag171-B61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2967\/jnumed.124.267869","article-title":"Nuclear cardiology surrogate biomarkers in clinical trials","volume":"66","author":"Miller","year":"2025","journal-title":"J Nucl Med"},{"key":"2026090105472083900_jeag171-B62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.acra.2014.09.001","article-title":"Methods and challenges in quantitative imaging biomarker development","volume":"22","author":"Abramson","year":"2015","journal-title":"Acad Radiol"},{"key":"2026090105472083900_jeag171-B63","article-title":"Statistical considerations for repeatability and reproducibility of quantitative imaging biomarkers","volume":"4","author":"Ye","year":"2022","journal-title":"BJR Open"},{"key":"2026090105472083900_jeag171-B64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"16","author":"Voigt","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B65","first-page":"337","article-title":"Impact of apical foreshortening on deformation measurements: a report from the EACVI-ASE strain standardization task force","volume":"21","author":"Unlu","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B66","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ehjci\/jeae147","article-title":"Standardization in paediatric echocardiographic reporting and critical interpretation of measurements, functional parameters, and prediction scores : a clinical consensus statement of the European Association of Cardiovascular Imaging of the European Society of Cardiology and the Association for European Paediatric and Congenital Cardiology","volume":"25","author":"Cantinotti","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","article-title":"Standardized image interpretation and post-processing in cardiovascular magnetic resonance\u20142020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing","volume":"22","author":"Schulz-Menger","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105472083900_jeag171-B68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105472083900_jeag171-B69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jcct.2016.10.002","article-title":"SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI)","volume":"10","author":"Abbara","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2026090105472083900_jeag171-B70","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s12350-016-0435-1","article-title":"Improving cardiac SPECT accuracy: old robustness for a new gold standard","volume":"24","author":"Gimelli","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"2026090105472083900_jeag171-B71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/09622802241227959","article-title":"A statistical framework for planning and analysing test-retest studies of repeatability","volume":"33","author":"Danzer","year":"2024","journal-title":"Stat Methods Med Res"},{"key":"2026090105472083900_jeag171-B72","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.echo.2015.06.011","article-title":"Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI\/ASE inter-vendor comparison study","volume":"28","author":"Farsalinos","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026090105472083900_jeag171-B73","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jcct.2024.09.009","article-title":"Interscan reproducibility of computed tomography derived coronary plaque volume measurements","volume":"18","author":"Iraqi","year":"2024","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2026090105472083900_jeag171-B74","article-title":"Reproducibility of quantitative myocardial perfusion and coronary flow capacity by positron emission tomography: 3D digital silicon photomultiplier solid state vs. legacy 2D analogue systems for clinical practice and trials","volume":"2","author":"Roby","year":"2024","journal-title":"Eur Heart J Imaging Methods Pract"},{"key":"2026090105472083900_jeag171-B75","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"2026090105472083900_jeag171-B76","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.013987","article-title":"Accuracy and reproducibility of myocardial blood flow quantification by single photon emission computed tomography imaging in patients with known or suspected coronary artery disease","volume":"15","author":"de Souza","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B77","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.echo.2024.01.001","article-title":"Precision of echocardiographic measurements","volume":"37","author":"Pillai","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"key":"2026090105472083900_jeag171-B78","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.echo.2019.08.015","article-title":"A practical guide to assess the reproducibility of echocardiographic measurements","volume":"32","author":"Bunting","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"2026090105472083900_jeag171-B79","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.240516","article-title":"Use of AI in cardiac CT and MRI: a scientific statement from the ESCR, EuSoMII, NASCI, SCCT, SCMR, SIIM, and RSNA","volume":"314","author":"Mastrodicasa","year":"2025","journal-title":"Radiology"},{"key":"2026090105472083900_jeag171-B80","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jeae333.037","article-title":"Operational feasibility and reproducibility of serial echocardiographic parameters of left ventricular remodelling and function for evaluation of drug efficacy in multicentre clinical trial settings","volume":"26","author":"Surkova","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B81","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijcard.2019.07.098","article-title":"Impact of heart rate on coronary computed tomographic angiography interpretability with a third-generation dual-source scanner","volume":"295","author":"Miller","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026090105472083900_jeag171-B82","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034029","article-title":"Reference values for indexed echocardiographic chamber sizes in older adults: the multi-ethnic study of atherosclerosis","volume":"13","author":"Strom","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026090105472083900_jeag171-B83","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ehjci\/jeab293","article-title":"Clinical applications of cardiac computed tomography: a consensus paper of the European association of cardiovascular imaging-part I","volume":"23","author":"Pontone","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B84","article-title":"Towards standardization of positron emission testing with computed tomography myocardial perfusion volumes and left ventricular ejection fraction: comparison with cardiac MRI","volume":"1","author":"Dong","year":"2023","journal-title":"Eur Heart J Imaging Methods Pract"},{"key":"2026090105472083900_jeag171-B85","volume-title":"Statistical Analysis with Missing Data","author":"Little","year":"2019"},{"key":"2026090105472083900_jeag171-B86","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJMsr1203730","article-title":"The prevention and treatment of missing data in clinical trials","volume":"367","author":"Little","year":"2012","journal-title":"N Engl J Med"},{"key":"2026090105472083900_jeag171-B87","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/jmri.24239","article-title":"CMR reference values for left ventricular volumes, mass, and ejection fraction using computer-aided analysis: the framingham heart study","volume":"39","author":"Chuang","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"2026090105472083900_jeag171-B88","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014645","article-title":"Optimal echocardiographic parameters to improve the diagnostic yield of tc-99m-bone avid tracer cardiac scintigraphy for transthyretin cardiac amyloidosis","volume":"15","author":"Cuddy","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B89","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jcmg.2021.07.029","article-title":"The future of cardiac magnetic resonance clinical trials","volume":"15","author":"Rabbat","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B90","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1532-429X-15-56","article-title":"T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision","volume":"15","author":"Kellman","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105472083900_jeag171-B91","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2967\/jnumed.120.246280","article-title":"Appropriate use criteria for PET myocardial perfusion imaging","volume":"61","author":"Schindler","year":"2020","journal-title":"J Nucl Med"},{"key":"2026090105472083900_jeag171-B92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12968-020-00607-1","article-title":"Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update","volume":"22","author":"Kramer","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105472083900_jeag171-B93","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jcct.2020.11.001","article-title":"SCCT 2021 expert consensus document on coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography","volume":"15","author":"Narula","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2026090105472083900_jeag171-B94","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/2168479016632271","article-title":"The impact of protocol amendments on clinical trial performance and cost","volume":"50","author":"Getz","year":"2016","journal-title":"Ther Innov Regul Sci"},{"key":"2026090105472083900_jeag171-B95","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"2026090105472083900_jeag171-B96","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0898010115594934","article-title":"The effect of reflective garden walking on adults with increased levels of psychological stress","volume":"34","author":"McCaffrey","year":"2016","journal-title":"J Holist Nurs"},{"key":"2026090105472083900_jeag171-B97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/ehjci\/jeag006","article-title":"Clinical applications of strain echocardiography: a clinical consensus statement from the American Society of Echocardiography Developed in Collaboration With the European Association of Cardiovascular Imaging of the European Society of Cardiology","volume":"27","author":"Thomas","year":"2026","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B98","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/eurheartj\/ehae574","article-title":"Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial","volume":"45","author":"Marwick","year":"2024","journal-title":"Eur Heart J"},{"key":"2026090105472083900_jeag171-B99","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.009905","article-title":"Global Cardio Oncology Registry (G-COR): registry design, primary objectives, and future perspectives of a multicenter global initiative","volume":"16","author":"Teske","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026090105472083900_jeag171-B100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jacc.2019.11.049","article-title":"Global longitudinal strain and cardiac events in patients with immune checkpoint inhibitor-related myocarditis","volume":"75","author":"Awadalla","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026090105472083900_jeag171-B101","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026090105472083900_jeag171-B102","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcmg.2020.07.043","article-title":"Reduction in CMR derived extracellular volume with patisiran indicates cardiac amyloid regression","volume":"14","author":"Fontana","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B103","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jcmg.2021.07.027","article-title":"The REPAIR study: effects of macitentan on RV structure and function in pulmonary arterial hypertension","volume":"15","author":"Noordegraaf A","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B104","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1093\/ehjci\/jead096","article-title":"Multimodality imaging for patient selection, procedural guidance, and follow-up of transcatheter interventions for structural heart disease: a consensus document of the EACVI Task Force on Interventional Cardiovascular Imaging: part 1: access routes, transcatheter aortic valve implantation, and transcatheter mitral valve interventions","volume":"24","author":"Agricola","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B105","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jcct.2025.04.007","article-title":"Cardiac computed tomography for prosthetic heart valve assessment. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the European Society of Cardiovascular Radiology (ESCR), the North American Society of Cardiovascular Imaging (NASCI), the Radiological Society of North America (RSNA), the Society for Cardiovascular Angiography & Interventions (SCAI) and Society of Thoracic Surgeons (STS)","volume":"19","author":"Budde","year":"2025","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2026090105472083900_jeag171-B106","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/ehjci\/jeac192","article-title":"How to quantify coronary atherosclerotic plaque using computed tomography","volume":"23","author":"Szilveszter","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B107","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehaa652","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial","volume":"41","author":"Budoff","year":"2020","journal-title":"Eur Heart J"},{"key":"2026090105472083900_jeag171-B108","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1093\/ehjci\/jeab053","article-title":"Multimodality imaging of myocardial viability: an expert consensus document from the European Association of Cardiovascular Imaging (EACVI)","volume":"22","author":"Almeida","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B109","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.2020190140","article-title":"Utility of FDG PET and cardiac MRI in diagnosis and monitoring of immunosuppressive treatment in cardiac sarcoidosis","volume":"2","author":"Coulden","year":"2020","journal-title":"Radiol Cardiothorac Imaging"},{"key":"2026090105472083900_jeag171-B110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B111","doi-asserted-by":"crossref","first-page":"118","DOI":"10.18383\/j.tom.2019.00031","article-title":"Standardization in quantitative imaging: a multicenter comparison of radiomic features from different software packages on digital reference objects and patient data sets","volume":"6","author":"McNitt-Gray","year":"2020","journal-title":"Tomography"},{"key":"2026090105472083900_jeag171-B112","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocmr.2026.102697","article-title":"Deep learning motion correction of quantitative stress perfusion cardiovascular magnetic resonance","volume":"28","author":"Schueler","year":"2026","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105472083900_jeag171-B113","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","article-title":"Myocardial interstitial fibrosis in heart failure: biological and translational perspectives","volume":"71","author":"Gonzalez","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026090105472083900_jeag171-B114","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-030-78771-4_11","article-title":"Tissue characterization in cardiology: moving beyond function","volume":"1337","author":"Markousis-Mavrogenis","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"2026090105472083900_jeag171-B115","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2019.06.030","article-title":"Myocardial tissue characterization and fibrosis by imaging","volume":"13","author":"Karamitsos","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B116","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/eurheartj\/ehae190","article-title":"Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography","volume":"45","author":"Nurmohamed","year":"2024","journal-title":"Eur Heart J"},{"key":"2026090105472083900_jeag171-B117","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s10554-020-01793-w","article-title":"A review of serial coronary computed tomography angiography (CTA) to assess plaque progression and therapeutic effect of anti-atherosclerotic drugs","volume":"36","author":"Taron","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B118","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jacc.2017.11.054","article-title":"Effect of plaque burden and morphology on myocardial blood flow and fractional flow reserve","volume":"71","author":"Driessen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026090105472083900_jeag171-B119","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcmg.2017.01.008","article-title":"Myocardial infarct size by CMR in clinical cardioprotection studies: insights from randomized controlled trials","volume":"10","author":"Bulluck","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B120","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jchf.2019.06.004","article-title":"Imaging, biomarker, and clinical predictors of cardiac remodeling in heart failure with reduced ejection fraction","volume":"7","author":"Aimo","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2026090105472083900_jeag171-B121","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/eurheartj\/ehac640","article-title":"Use of cardiac imaging in chronic coronary syndromes: the EURECA imaging registry","volume":"44","author":"Neglia","year":"2023","journal-title":"Eur Heart J"},{"key":"2026090105472083900_jeag171-B122","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"2026090105472083900_jeag171-B123","article-title":"Randomized or real-world? Integrating imaging evidence for clinical practice","volume":"3","author":"Frumento","year":"2025","journal-title":"Eur Heart J Imaging Methods Pract"},{"key":"2026090105472083900_jeag171-B124","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13063-023-07092-8","article-title":"Minimum important difference is minimally important in sample size calculations","volume":"24","author":"Wong","year":"2023","journal-title":"Trials"},{"key":"2026090105472083900_jeag171-B125","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacc.2009.06.065","article-title":"Trial and error. How to avoid commonly encountered limitations of published clinical trials","volume":"55","author":"Kaul","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026090105472083900_jeag171-B126","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jacr.2025.09.013","article-title":"Green imaging: scoping review of radiology's environmental impact","volume":"23","author":"Woolen","year":"2026","journal-title":"J Am Coll Radiol"},{"key":"2026090105472083900_jeag171-B127","article-title":"The environmental impact of medical imaging agents and the roadmap to sustainable medical imaging","volume":"12","author":"Pichler","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"2026090105472083900_jeag171-B128","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072491","article-title":"Carbon footprint of industry-sponsored late-stage clinical trials","volume":"13","author":"Mackillop","year":"2023","journal-title":"BMJ Open"},{"key":"2026090105472083900_jeag171-B129","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-088600","article-title":"What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials","volume":"14","author":"Griffiths","year":"2024","journal-title":"BMJ Open"},{"key":"2026090105472083900_jeag171-B130","article-title":"Society for Cardiovascular Magnetic Resonance recommendations toward environmentally sustainable cardiovascular magnetic resonance","volume":"27","author":"Hanneman","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105472083900_jeag171-B131","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1093\/eurheartj\/ehac716","article-title":"Economic, ethical, and environmental sustainability of cardiac imaging","volume":"44","author":"Picano","year":"2023","journal-title":"Eur Heart J"},{"key":"2026090105472083900_jeag171-B132","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcmg.2016.10.016","article-title":"Comparative effectiveness trials of imaging-guided strategies in stable ischemic heart disease","volume":"10","author":"Shaw","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B133","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12968-018-0471-x","article-title":"Automated cardiovascular magnetic resonance image analysis with fully convolutional networks","volume":"20","author":"Bai","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105472083900_jeag171-B134","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12968-022-00846-4","article-title":"Precision measurement of cardiac structure and function in cardiovascular magnetic resonance using machine learning","volume":"24","author":"Davies","year":"2022","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105472083900_jeag171-B135","article-title":"Precision, prognosis, and clinical performance of rounded and trabecular segmentation of cine cardiovascular magnetic resonance","volume":"28","author":"Joy","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026090105472083900_jeag171-B136","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1038\/s41467-022-34245-1","article-title":"A formal validation of a deep learning-based automated workflow for the interpretation of the echocardiogram","volume":"13","author":"Tromp","year":"2022","journal-title":"Nat Commun"},{"key":"2026090105472083900_jeag171-B137","doi-asserted-by":"crossref","first-page":"20484","DOI":"10.1038\/s41598-024-71530-z","article-title":"A multi-task deep learning approach for real-time view classification and quality assessment of echocardiographic images","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"2026090105472083900_jeag171-B138","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1093\/eurheartj\/ehz592","article-title":"A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography","volume":"40","author":"Oikonomou","year":"2019","journal-title":"Eur Heart J"},{"key":"2026090105472083900_jeag171-B139","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s44161-025-00757-4","article-title":"A multimodal vision knowledge graph of cardiovascular disease","volume":"5","author":"Rjoob","year":"2026","journal-title":"Nat Cardiovasc Res"},{"key":"2026090105472083900_jeag171-B140","article-title":"Between hope and hype: assessing artificial intelligence in cardiovascular imaging","volume":"3","author":"Fortuni","year":"2025","journal-title":"Eur Heart J Imaging Methods Pract"},{"key":"2026090105472083900_jeag171-B141","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/jama.2012.442","article-title":"Continuous patient engagement in comparative effectiveness research","volume":"307","author":"Mullins","year":"2012","journal-title":"JAMA"},{"key":"2026090105472083900_jeag171-B142","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s43441-020-00185-5","article-title":"Determining the suitability of registries for embedding clinical trials in the United States: a project of the clinical trials transformation initiative","volume":"55","author":"Mikita","year":"2021","journal-title":"Ther Innov Regul Sci"},{"key":"2026090105472083900_jeag171-B143","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jcmg.2023.12.007","article-title":"Ultrasound shear wave elastography in cardiology","volume":"17","author":"Caenen","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B144","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/ehjci\/jeaf200","article-title":"Ultrasound shear wave elastography for detection of myocardial fibrosis","volume":"26","author":"Petrescu","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B145","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032571","article-title":"Effect of denosumab or alendronate on vascular calcification: secondary analysis of SALTIRE2 randomized controlled trial","volume":"13","author":"Geers","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026090105472083900_jeag171-B146","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(11)61383-4","article-title":"Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial","volume":"378","author":"Fayad","year":"2011","journal-title":"Lancet"},{"key":"2026090105472083900_jeag171-B147","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacc.2024.10.103","article-title":"Myocardial fibroblast activation after acute myocardial infarction: a positron emission tomography and magnetic resonance study","volume":"85","author":"Barton","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026090105472083900_jeag171-B148","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/ehjci\/jeae224","article-title":"CMR to characterize myocardial structure and function in heart failure with preserved left ventricular ejection fraction","volume":"25","author":"Ipek","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B149","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2025.07.022","article-title":"Photon-counting computed tomography in cardiac imaging","volume":"19","author":"Shiyovich","year":"2026","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B150","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf1118","article-title":"Photon-counting computed tomography: a revolution in cardiac imaging","author":"Pontone","year":"2026","journal-title":"Eur Heart J"},{"key":"2026090105472083900_jeag171-B151","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.123.015490","article-title":"Perfect match: radiomics and artificial intelligence in cardiac imaging","volume":"17","author":"Baessler","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B152","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ehjci\/jeae238","article-title":"How to conduct clinical research in cardiovascular imaging: a primer for clinical cardiologists and researchers-a statement of the European Association of Cardiovascular Imaging (EACVI) of the ESC","volume":"26","author":"Muraru","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B153","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcmg.2017.01.009","article-title":"Primary prevention of CVD: the role of imaging trials","volume":"10","author":"Rozanski","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026090105472083900_jeag171-B154","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.drudis.2021.07.025","article-title":"Positron emission tomographic imaging in drug discovery","volume":"27","author":"Ghosh","year":"2022","journal-title":"Drug Discov Today"},{"key":"2026090105472083900_jeag171-B155","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0735-1097(94)00353-R","article-title":"Evidence for reduction of norepinephrine uptake sites in the failing human heart","volume":"25","author":"Bohm","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2026090105472083900_jeag171-B156","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s00259-012-2204-y","article-title":"LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment","volume":"39","author":"Yu","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026090105472083900_jeag171-B157","doi-asserted-by":"crossref","DOI":"10.1177\/1536012117749052","article-title":"Commentary to (18)F-GP1, a novel PET tracer designed for high-sensitivity, low-background detection of thrombi: imaging activated platelets in clots-are we getting there?","volume":"17","author":"Stephens","year":"2018","journal-title":"Mol Imaging"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeag171\/68663572\/jeag171.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/9\/1585\/68663572\/jeag171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/9\/1585\/68663572\/jeag171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:48:20Z","timestamp":1788256100000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/9\/1585\/8722780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":157,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeag171","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,7,1]]}}}